mesoblasts

Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) TherapyMesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

Mesoblasts RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy

December 18, 2024 19:08 ET  | Source: Mesoblast Limited RYONCIL (remestemcel-L) is the first MSC product approved by FDA for…

4 months ago